A detailed history of Eudaimonia Advisors LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Eudaimonia Advisors LLC holds 3,585 shares of ABT stock, worth $364,379. This represents 0.22% of its overall portfolio holdings.

Number of Shares
3,585
Holding current value
$364,379
% of portfolio
0.22%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

BUY
$109.52 - $120.96 $392,629 - $433,641
3,585 New
3,585 $407,000
Q4 2022

Jan 24, 2023

SELL
$95.06 - $111.52 $15,304 - $17,954
-161 Reduced 6.95%
2,157 $0
Q3 2022

Nov 03, 2022

BUY
$96.76 - $112.03 $13,352 - $15,460
138 Added 6.33%
2,318 $224,000
Q2 2022

Aug 09, 2022

BUY
$102.07 - $123.37 $15,208 - $18,382
149 Added 7.34%
2,180 $237,000
Q1 2022

May 16, 2022

BUY
$114.02 - $139.04 $231,574 - $282,390
2,031 New
2,031 $240,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $178B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Eudaimonia Advisors LLC Portfolio

Follow Eudaimonia Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eudaimonia Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eudaimonia Advisors LLC with notifications on news.